Share of biosimilars on the total marketed products in Italy in 2022, by molecule

Published by
Juliette Gagliardi,
Jul 12, 2023
According to data, Filgrastim, Rituximab, and Infliximab were the molecules for which the share of biosimilar variations on the total marketed products was higher. More specifically, the biosimilar drugs produced from Filgrastim accounted for 97.23 percent of the total sales of this molecule, while all the other products represented 2.77 percent of the market. The graph displays the share of biosimilar drugs consumption on the total marketed products in Italy in 2022, by molecule.

Share of biosimilar drugs consumption on the total marketed products in Italy 2022, by molecule

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2023

Region

Italy

Survey time period

2022

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars in Italy

Global overview

6

Generic drugs overview

7

Generics' expenditure

5

Generics' consumption

3

Biosimilar drugs

5

Outlook

5

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilars in ItalyTop pharmaceutical drugsHealth and food supplements market in ItalyNon-prescription drugs in ItalyPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu